header bar
  LeukemiaLinks - Your Link to the Latest Leukemia News  


JULY 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and events sponsored by The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Leukemia News

Taking Aim at Relapse of Leukemia in Kids
Scientists have identified molecules that enable tumor cells to invade the nervous system of patients with a blood-borne childhood cancer. Study leader Ioannis Aifantis is funded by LLS as a Scholar in our Career Development research grant program
.

::READ MORE NEWS::

LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month   
:: READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. The LLS LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own. This month, read about Robert K. Brown.

Here to Help

For even more information, regularly visit the LLS Web site,
www.LLS.org, where many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in LeukemiaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

 

 

Researcher Image

Clinical Trials
We invite you to use our LLS-supported TrialCheck® Web site , a clinical trial search service that offers patients and caregivers immediate access to listings of all leukemia clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy to read list of search results. 

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute. :: SELECTED TRIALS::



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
::CLICK HERE TO SIGN UP ::


bottom bar

Latest Leukemia News

news image

Obesity and Smoking Tied to Myelodysplastic Syndromes
Although factors such as diet and alcohol consumption do not seem to affect the risk of myelodysplastic syndromes (MDS), tobacco use and body mass index (BMI) are associated with these conditions, researchers report in the June 15th issue of the American Journal of Epidemiology.

Cranial Irradiation can be Safely Omitted in Children with Acute Lymphoblastic Leukemia
Prophylactic cranial irradiation had once been a standard treatment for childhood ALL, but more and more clinicians are now replacing it with intrathecal and systemic chemotherapy in hopes of avoiding late radiation-associated complications, according to the report in The New England Journal of Medicine for June 25.

> Back to the top

LLS Features

calendar image

My Personal CLL Journey
LLS is proud to offer My Personal CLL Journey, an interactive program following the story and experience of Mike, a CLL survivor. Kanti Rai, MD, of the Long Island Jewish Hospital and nurse practitioner Nancy Driscoll provide expert insights along the way. Learn More.

My Personal CML Journey
LLS is proud to offer My Personal CML Journey, an interactive, online video education program. The feature follows the stories and experiences of two chronic myelogenous leukemia (CML) survivors. Learn more.

My Clinical Trials Journey
Participate in this personalized and interactive program that follows the stories and experiences of three cancer survivors who have participated in clinical trials.

Co-Pay Assistance Program Broadens Funding
Qualified patients with chronic myelogenous leukemia can now receive up to $5,000 in assistance from LLS' Co-Pay Assistance Program. The aid helps offset prescription drug co-pays and other insurance-related expenses according to disease diagnosis.

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard. 

ACT NOW: Urge Your Senators to Support Increased Cancer Research Funding
 
Patient Services Survey
Please give us your feedback by completing LLS Disease & Treatment Publications - Survey for Patients, Family and Friends.

LLS Blog


The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families.
Learn the many ways you can help advance LLS's mission. 
 


> Back to the top

Research Roundup

links_image_micro2


A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.  ::READ MORE::

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.  ::READ MORE::

Treatment of fludarabine-refractory chronic lymphocytic leukemia.  ::READ MORE::

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia.  ::READ MORE::

Executive function, coping, and behavior in survivors of childhood acute lymphocytic leukemia.  ::READ MORE::

> Back to the top

Clinical Trials
Clinical Trials Image Selected Trials

Laboratory-Treated Peripheral Blood Lymphocytes With or Without Chemotherapy in Treating Patients with Progressive B-Cell Lymphoma or Chronic Lymphocytic Leukemia  ::READ MORE::

Phase III: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia  ::READ MORE::

Open Label Study of Subcutaneous Homoharringtonine in Patients with Advanced CML  ::READ MORE::

A Phase III Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia  ::READ MORE:: 

> Back to the top

IRC Question of the Month
Q&A

Q: I have gotten a side effect from chemotherapy called peripheral neuropathy, are there any treatments for this condition, as it affects my daily life?
 
A: Peripheral neuropathy (PN) is the term for damage to nerves of the peripheral nervous system, which transmits information from the brain and spinal cord to other parts of the body. PN is estimated to affect 10 to 20 percent of people with cancer and can be caused by certain chemotherapeutic agents, such as vincristine (Oncovin®), bortezomib (Velcade®), thalidomide (Thalomid®), lenalidomide (Revlimid®), cytarabine (Cytosar-U®), interferon (multiple brand names) or methotrexate (multiple brand names). Radiation therapy may cause nerve injury, although it may take several years for symptoms to appear. Shingles, a rash that may develop in people with weakened immune systems, may also result in neuropathy. PN may also be a symptom of certain diseases, such as myeloma.

Some causes of PN are not associated with cancer. PN may be inherited or it can be a symptom of certain diseases or conditions. It is important to let your doctor know if you already have symptoms of neuropathy before starting treatment, or if you have any of the conditions that are associated with PN, including diabetes, nerve compression caused by vertebral fractures or vitamin deficiencies, particularly folate or vitamin B12, autoimmune diseases, such as lupus and rheumatoid arthritis, hypothyroidism or kidney disease.

While a person is undergoing cancer treatment, his or her doctor may give prescribe certain medications and/or vitamins to help prevent neuropathy. Be sure to talk with your doctor before starting any over-the-counter medications, vitamins, or supplements on your own. Patients should seek medical advice as soon as possible if they experience numbness, tingling, burning, coldness or weakness in the arms or legs. These may be symptoms of PN.

With medical advice, patients who develop PN as a result of chemotherapy may be helped by taking a reduced dosage of the prescribed drugs or stopping the drugs completely. Treatment-caused PN may gradually decrease after treatment is completed. In some cases, the symptoms may persist.  Other therapies for PN depend on its cause and related symptoms. Many people recover fully from the disorder over time, whether it is in a few months or a few years. Sometimes, the condition may be more difficult to cure and may require long-term management. Your doctor will work to diagnose and eliminate the cause of your neuropathy and manage symptoms.

These safety tips from the American Society of Clinical Oncology at Cancer.Net may help people with PN who have sensory or motor difficulties to avoid injury at home:

  • Keep all rooms, hallways, and stairways well lit.
  • Install handrails on both sides of stairways.
  • Remove small area rugs and any other clutter that you could trip over or slip on.
  • Install grab bars in the shower or handgrips in the tub, and lay down skid-free mats.
  • Use a thermometer to check that any water you bathe in or use is below 110 degrees Fahrenheit, or set your water heater accordingly.
  • Clean up any spilled water or liquids immediately.
  • Use non-breakable dishes.
  • Use potholders while cooking and rubber gloves when washing dishes.
  • If you drive, make sure you can fully feel the gas and brake pedals, and the steering wheel, and that you can quickly move your foot from the gas to the brake.
  • If prescribed, use a cane or walker when moving from one room to the other.

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.


> Back to the top

Supported by an unrestricted
educational grant from
Allos Therapeutics, Inc Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.